The Skin Care Products Third-party Testing Services segmentation by application is anchored in five principal sub‑segments that collectively shape market revenue. Safety & Toxicology Testing—covering acute dermal irritation, sensitization, and genotoxicity—accounts for roughly 30 % of total spend, driven by stringent regulatory mandates across North America and the EU. Stability Testing, representing 25 % of the market, validates product shelf‑life under varied temperature and humidity regimes, a prerequisite for global distribution. Efficacy Testing (20 %) quantifies performance claims such as anti‑aging or moisturization through in‑vitro and in‑vivo protocols, influencing premium pricing strategies. Regulatory Compliance Testing (15 %) ensures conformity with labeling, ingredient limits, and prohibited substance lists, a critical cost for manufacturers entering new jurisdictions. Finally, Cosmetic Formulation Testing (10 %) assesses compatibility of active ingredients with base matrices, supporting formulation optimisation. Each application segment contributes proportionally to the overall market size, reflecting the risk‑mitigation priorities and product development cycles of skin‑care manufacturers.